Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Background. The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses remains unknown. We evaluated drug concentrations in plasma, human immunodeficiency virus (HIV) load, and development of...
Saved in:
Main Authors: | Cressey T.R., Green H., Khoo S., Treluyer J.-M., Compagnucci A., Saidi Y., Lallemant M., Gibb D.M., Burger D.M. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-43249121119&partnerID=40&md5=70cde227052f32d5d5b16fff84a6ff30 http://www.ncbi.nlm.nih.gov/pubmed/18419497 http://cmuir.cmu.ac.th/handle/6653943832/729 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
by: Tim R. Cressey, et al.
Published: (2018) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: Puthanakit T., et al.
Published: (2014) -
HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
by: T. Puthanakit, et al.
Published: (2018)